MedPath

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study

Conditions
Hypertension
Metabolic Syndrome
First Posted Date
2010-03-09
Last Posted Date
2010-03-16
Lead Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Target Recruit Count
240
Registration Number
NCT01082835
Locations
🇨🇳

Beijing Medical University ,Dongzhimen Hospital, Beijing, Beijing, China

🇨🇳

Beijing Medical University,Dongfang Hospital, Beijing, Beijing, China

🇨🇳

China Academy of Chinese Medical Sciences,Guang'anmen Hospital, Beijing, Beijing, China

and more 2 locations

The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients

Not Applicable
Conditions
Acquired Immune Deficiency Syndrome Virus
HIV Infections
Interventions
Drug: Fuzheng 3
Drug: Fuzheng 1
Drug: Placebo
First Posted Date
2009-09-10
Last Posted Date
2009-10-29
Lead Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Target Recruit Count
180
Registration Number
NCT00974519
Locations
🇨🇳

Jie, WANG, Beijing, Beijing, China

Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients

Not Applicable
Conditions
Acquired Immune Deficiency Syndrome Virus
HIV Infections
Interventions
Drug: Fuzheng 1
Drug: Placebo
First Posted Date
2009-09-10
Last Posted Date
2009-10-29
Lead Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Target Recruit Count
60
Registration Number
NCT00974285
Locations
🇨🇳

Jie, WANG, Beijing, Beijing, China

Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)

Not Applicable
Conditions
Acquired Immune Deficiency Syndrome Virus
HIV Infections
Interventions
Drug: Fuzheng 2
Drug: Placebo
First Posted Date
2009-09-10
Last Posted Date
2009-10-29
Lead Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Target Recruit Count
180
Registration Number
NCT00974454
Locations
🇨🇳

Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, China

Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

Not Applicable
Completed
Conditions
Coronary Heart Disease
Interventions
Drug: Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules,
Drug: Sheng Mai Capsules Plus Placebo of Xuefu Zhuyu Capsules
Drug: Placebo of Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules
First Posted Date
2009-01-06
Last Posted Date
2012-06-01
Lead Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Target Recruit Count
90
Registration Number
NCT00817024
Locations
🇨🇳

Guang'an Men Hospital, Beijing, China

A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation

Phase 2
Completed
Conditions
Constipation
Interventions
Other: deep needling
Other: shallow needling
First Posted Date
2007-07-30
Last Posted Date
2014-06-04
Lead Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Target Recruit Count
475
Registration Number
NCT00508482
Locations
🇨🇳

Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath